Nurse Anesthetist - CR in Riverton, UT Accepting Medicare

4 Nurse Anesthetist - CR nurses found. Showing 1 - 4

Samantha Blair Walker, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3741 W 12600 S, Riverton, UT 84065 Phone: 801-727-2056    Fax: 770-701-6675

Henna Kealohilani Brown Jr., CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3741 W 12600 S, Riverton, UT 84065 Phone: 801-285-4000

Larissa J Bruck, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 3741 W 12600 S, Riverton, UT 84065 Phone: 801-285-4000

Jensen Willard, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 3741 W 12600 S, Riverton, UT 84065 Phone: 801-285-4000

News Archive

New bioinformatics software tool to identify genetic mutations responsible for cancers

Researchers at the Medical College of Wisconsin (MCW) have developed a new bioinformatics software tool designed to more easily identify genetic mutations responsible for cancers. The tool, called DrGaP, is the subject of a new paper published in the American Journal of Human Genetics.

Fingerprint sampling could help police distinguish between drug users and non-users

Researchers have developed a tool that can determine whether someone has used heroin, even if they have washed their hands.

Rhythm presents RM-131 Phase 1 clinical trial results for diabetic gastroparesis at ACG 2012

Rhythm announced today the results of two Phase 1 clinical trials of RM-131, the company's novel ghrelin agonist for the treatment of diabetic gastroparesis, which demonstrated that RM-131 greatly accelerates gastric emptying in healthy subjects with good tolerability.

ACP urges health professionals to speak out on mass deportation of immigrants

The American College of Physicians (ACP) today called on physicians, individually and collectively, to speak out against proposals to deport the 12 million U.S. residents who lack documentation of legal residency status, citing the adverse impact that mass deportation would have on individual and the health of the public.

Positive top-line results from Phenomix' Phase 3 trial of dutogliptin for Type 2 diabetes mellitus

Phenomix Corporation today announced positive top-line results from a six-month Phase 3 study comparing dutogliptin 400mg and 200mg once daily as monotherapy versus placebo for the treatment of patients with Type 2 diabetes mellitus. Dutogliptin is Phenomix' internally-discovered dipeptidyl peptidase-4 (DPP-4) inhibitor.

Read more Medical News

› Verified 6 days ago